A. Lerner, M. Arleevskaya, A. Schmiedl, and T. Matthias, Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes? Front Microbiol, vol.8, p.28824555, 2017.

H. De-souza, C. Fiocchi, and D. Iliopoulos, The IBD interactome: an integrated view of aetiology, pathogenesis and therapy, Nat Rev Gastroenterol Hepatol, vol.14, p.28831186, 2017.

J. Wang, F. Li, and Z. Tian, Role of microbiota on lung homeostasis and diseases, Sci China Life Sci, vol.60, p.29019144, 2017.

H. D. Williams and J. C. Davies, Basic science for the chest physician: Pseudomonas aeruginosa and the cystic fibrosis airway, Thorax, vol.67, p.22382597, 2012.

A. R. Smyth and M. N. Hurley, Targeting the Pseudomonas aeruginosa biofilm to combat infections in patients with cystic fibrosis, Drugs Fut, vol.35, pp.1007-1014, 2010.

A. Folkesson, L. Jelsbak, L. Yang, H. K. Johansen, O. Ciofu et al., Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective, Nat Rev Microbiol, vol.10, p.23147702, 2012.

R. Sabino, J. A. Ferreira, R. B. Moss, J. Valente, C. Veríssimo et al., Molecular epidemiology of Aspergillus collected from cystic fibrosis patients, J Cyst Fibros, vol.14, p.25459562, 2015.

J. Fillaux, F. Brémont, M. Murris, S. Cassaing, J. L. Rittié et al., Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients, Scand J Infect Dis, vol.44, p.22831545, 2012.

J. J. Speirs, C. K. Van-der-ent, and J. M. Beekman, Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis, Curr Opin Pulm Med, vol.18, p.22965276, 2012.

K. A. Ramsey, S. Ranganathan, J. Park, B. Skoric, A. M. Adams et al., Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis, Am J Respir Crit Care Med, vol.190, p.25321321, 2014.

K. De-boer, K. L. Vandemheen, E. Tullis, S. Doucette, D. Fergusson et al., Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis, Thorax, vol.66, p.21680566, 2011.

T. Nicolai, S. Arleth, A. Spaeth, R. M. Bertele-harms, and H. K. Harms, Correlation of IgE antibody titer to Af with decreased lung function in cystic fibrosis, Pediatr Pulmonol, vol.8, p.2405341, 1990.

K. D. Forsyth, A. W. Hohmann, A. J. Martin, and J. Bradley, IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity, Arch Dis Child, vol.63, p.3046514, 1988.

H. Schønheyder, T. Jensen, N. Høiby, P. Andersen, and C. Koch, Frequency of Aspergillus fumigatus isolates and antibodies to Aspergillus antigens in cystic fibrosis, Acta Pathol Microbiol Immunol Scand B, vol.93, p.3893030, 1985.

C. A. Coughlan, S. H. Chotirmall, J. Renwick, T. Hassan, T. B. Low et al., The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis, Am J Respir Crit Care Med, vol.186, p.22904183, 2012.

B. Mirkovi?, G. M. Lavelle, A. A. Azim, K. Helma, F. S. Gargoum et al., The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis, J Allergy Clin Immunol, vol.137, p.26388311, 2016.

C. G. Baxter, C. B. Moore, A. M. Jones, A. K. Webb, and D. W. Denning, IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis, Chest, vol.143, p.23139075, 2013.

D. Shoseyov, K. G. Brownlee, S. P. Conway, and E. Kerem, Aspergillus bronchitis in cystic fibrosis, Chest, vol.130, p.16840406, 2006.

R. Amin, A. Dupuis, S. D. Aaron, and F. Ratjen, The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis, Chest, vol.137, p.19567494, 2010.

S. De-bentzmann, P. , and P. , The Pseudomonas aeruginosa opportunistic pathogen and human infections, Environ Microbiol, vol.13, p.21450006, 2011.

T. J. Walsh and D. A. Stevens, Aspergillosis. Chapter, vol.347, 2011.

A. Mangan, Interactions between some aural Aspergillus species and bacteria, J Gen Microbiol, vol.58, p.4982824, 1969.

W. Blyth and A. Forey, The influence of respiratory bacteria and their biochemical fractions on Aspergillus fumigatus, Sabouraudia, vol.9, p.5002653, 1971.

J. R. Kerr, G. W. Taylor, A. Rutman, N. Høiby, P. J. Cole et al., Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth, J Clin Pathol, vol.52, p.10560362, 1999.

B. Briard, P. Bomme, B. E. Lechner, G. L. Mislin, V. Lair et al., Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines, Sci Rep, vol.5, issue.8220, p.25665925, 2015.

G. Sass, H. Nazik, J. Penner, H. Shah, S. R. Ansari et al., Studies of Pseudomonas aeruginosa mutants indicate pyoverdine as the central factor in inhibition of Aspergillus fumigatus biofilm, J Bacteriol, pp.345-362, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01854599

P. Cornelis and J. Dingemans, Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections, Front Cell Infect Microbiol, vol.3, p.24294593, 2013.

M. Y. Andrews, C. M. Santelli, and O. W. Duckworth, Layer plate CAS assay for the quantitation of siderophore production and determination of exudation patterns for fungi, J Microbiol Methods, vol.121, p.26712125, 2016.

E. Reece, S. Doyle, P. Greally, J. Renwick, and S. Mcclean, Aspergillus fumigatus inhibits Pseudomonas aeruginosa in co-culture: Implications of a mutually antagonistic relationship on virulence and inflammation in the CF airway, Front Microbiol, vol.9, p.29922270, 2018.

J. A. Sugui, J. Pardo, Y. C. Chang, K. A. Zarember, G. Nardone et al., Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone, Eukaryot Cell, vol.6, p.17601876, 2007.

H. Nazik, J. C. Penner, J. A. Ferreira, J. A. Haagensen, K. Cohen et al., Effects of iron chelators on the formation and development of Aspergillus fumigatus biofilm, Antimicrob Agents Chemother, vol.59, p.26239975, 2015.

J. L. Hsu, K. V. Clemons, O. Manouvakhova, M. Inayathulla, A. B. Tu et al., Microhemorrhage-associated tissue iron enhances the risk for Aspergillus fumigatus invasion in murine airway transplantation, pii: eaag2616, vol.10, 2018.

D. A. Stevens, Systemic antifungal agents. Cecil Textbook of Medicine, 2015.

M. Del-campo, J. S. Vogelaar, N. Tolani, K. Kizjakina, K. Harich et al., Inhibition of the flavindependent monooxygenase siderophore A (SidA) blocks siderophore biosynthesis and Aspergillus fumigatus growth, ACS Chem Biol, vol.11, p.27588426, 2016.

J. Potrykus, E. R. Ballou, D. S. Childers, and A. Brown, Conflicting interests in the pathogen?host tug of war: Fungal micronutrient scavenging versus mammalian nutritional immunity, PLoS Pathog, vol.10, p.24626223, 2014.

A. Hissen, J. Chow, L. J. Pinto, and M. M. Moore, Survival of Aspergillus fumigatus in serum involves removal of iron from transferrin: the role of siderophores, Infect Immun, vol.72, p.14977945, 2004.

V. Braun and H. Killmann, Bacterial solutions to the iron-supply problem, Trends Biochem Sci, vol.24, pp.104-109, 1999.

A. Khan, P. Singh, and A. Srivastava, Synthesis, nature and utility of universal iron chelator-Siderophore: A review, Microbiol Res, issue.17, pp.30673-30673, 2017.

P. Visca, F. Imperi, and I. L. Lamont, Pyoverdine siderophores: from biogenesis to biosignificance, Trends Microbiol, vol.15, p.17118662, 2007.

A. Blanc, S. , R. N. Ocacktan, A. Z. Abdallah, and M. A. , Bacterial iron transport: coordination properties of pyoverdin PaA, a peptidic siderophore of Pseudomonas aeruginosa, Inorg Chem, vol.33, pp.6391-6402, 1994.
URL : https://hal.archives-ouvertes.fr/hal-01458140

J. M. Meyer, Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species, Arch Microbiol, vol.174, p.11041343, 2000.

F. Imperi, F. Massai, M. Facchini, E. Frangipani, D. Visaggio et al., Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity, Proc Natl Acad Sci USA, vol.110, p.23569238, 2013.

R. G. Ankenbauer, T. Toyokuni, A. Staley, K. L. Rinehart, and C. D. Cox, Synthesis and biological activity of pyochelin, a siderophore of Pseudomonas aeruginosa, J Bacteriol, vol.170, p.3141386, 1988.

J. Brandel, N. Humbert, M. Elhabiri, I. J. Schalk, G. L. Mislin et al., Pyochelin, a siderophore of Pseudomonas aeruginosa: physicochemical characterization of the iron(III), copper(II) and zinc(II) complexes, Dalton Trans, vol.41, p.22261733, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00783434

E. Lopez-medina, F. D. Coughlin, L. A. Ho, E. X. Lamont, I. L. Reimmann et al., Candida albicans inhibits Pseudomonas aeruginosa virulence through suppression of pyochelin and pyoverdine biosynthesis, PLoS Pathog, vol.11, p.26313907, 2015.

H. Haas, Fungal siderophore metabolism with a focus on Aspergillus fumigatus, Nat Prod Rep, vol.31, p.25140791, 2014.

M. Blatzer, M. Schrettl, B. Sarg, H. H. Lindner, K. Pfaller et al., SidL, an Aspergillus fumigatus transacetylase involved in biosynthesis of the siderophores ferricrocin and hydroxyferricrocin, Appl Environ Microbiol, vol.77, p.21622789, 2011.

R. E. Tiedemann, J. Schmidt, J. J. Keats, C. Shi, Y. X. Zhu et al., Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-B with antimyeloma activity in vitro and in vivo, Blood, vol.113, p.19096011, 2008.

H. Zhu, X. W. Liu, T. Y. Cai, J. Cao, C. X. Tu et al., Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway, J Pharmacol Exp Ther, vol.334, p.20472666, 2010.

D. H. Kim, E. K. Shin, Y. H. Kim, B. W. Lee, J. G. Jun et al., Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii, European Journal of Clinical Investigation, vol.39, pp.819-827, 2010.

S. H. Venkatesha, H. Yu, R. Rajaiah, L. Tong, and K. D. Moudgil, Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses, Journal of Biological Chemistry, vol.286, p.21402700, 2011.

A. C. Allison, R. Cacabelos, V. Lombardi, X. A. Alvarez, and C. Vigo, Celastrol, a potent antioxidant and antiinflammatory drug, as a possible treatment for Alzheimer's disease, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.25, p.11513350, 2001.

J. Savulescu, Thalassaemia major: The murky story of deferiprone, BMJ, vol.328, p.14962851, 2004.

P. N. Paradkar, D. Domenico, I. Durchfort, N. Zohn, I. Kaplan et al., Iron depletion limits intracellular bacterial growth in macrophages, Blood, vol.112, p.18369153, 2008.